Drug Type Induced pluripotent stem cells (iPSC), Neural stem cell therapy |
Synonyms Human motor neural progenitor cell, HNPC 02, HNPC-02 |
Target- |
Action- |
Mechanism Cell replacements |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Preclinical | China | 25 Jul 2022 | |
Spinal Cord Injuries | Preclinical | China | 25 Jul 2022 |